Metirosine

From Wikipedia, the free encyclopedia

Metirosine chemical structure
Metirosine
Systematic (IUPAC) name
2-amino-3-(4-hydroxyphenyl)-2-methyl-propanoic acid
Identifiers
CAS number 672-87-7
ATC code C02KB01
PubChem 10123
Chemical data
Formula C10H13N1O3
Mol. weight 195.215
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life 3.4 - 3.7 hours
Excretion  ?
Therapeutic considerations
Pregnancy cat.

?

Legal status
Routes  ?

[edit] Mechanism of action

Metirosine is an antihypertensive drug. It inhibits the enzyme tyrosine hydroxylase and, therefore, catecholamine synthesis.

[edit] Clinical Use

Metirosine is used in the treatment of phaeochromocytoma. It is contra-indicated for the treatment of essential hypertension.


Antihypertensives (C02) and diuretics (C03) edit
Antiadrenergic agents (including alpha):

Clonidine, Doxazosin, Guanethidine, Guanfacine, Lofexidine, Mecamylamine, Methyldopa, Moxonidine, Prazosin, Rescinnamine, Reserpine

Vasodilators:

Diazoxide, Hydralazine, Minoxidil, Nitroprusside, Phentolamine

Other antihypertensives:

Bosentan, Ketanserin

Low ceiling diuretics:

Bendroflumethiazide, Chlorothiazide, Chlortalidone, Hydrochlorothiazide, Indapamide, Quinethazone, Mersalyl, Metolazone, Theobromine

High ceiling diuretics:

Bumetanide, Furosemide, Torasemide

Potassium-sparing diuretics:

Amiloride, Eplerenone, Spironolactone, Triamterene